Ticker Details
Johnson & Johnson Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$584.38B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.70 | 0.65%
Avg Daily Range (30 D):	$1.99 | 0.88%
Avg Daily Range (90 D):	$1.59 | 0.75%

Institutional Daily Volume
Avg Daily Volume:	7.95M
Avg Daily Volume (30 D):	7.44M
Avg Daily Volume (90 D):	6.45M

Trade Size
Avg Trade Size (Sh.):	136
Avg Trade Size (Sh.) (30 D):	42
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	160,424
Avg Institutional Trade:	$8.44M
Avg Institutional Trade (30 D):	$32.31M
Avg Institutional Trade (90 D):	$30.5M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	28

Market Closing Trades
Avg Closing Trade:	$122.34M
Avg Closing Trade (30 D):	$360.71M
Avg Closing Trade (90 D):	$346.32M
Avg Closing Volume:	937.02K

News

Feb 23, 2026 @ 5:35 PM 3 Vanguard ETFs to Buy That Are Crushing the S&P 5... Source: Daniel Foelber

Feb 22, 2026 @ 6:02 PM Johnson & Johnson: This Dividend King Could Anchor... Source: Justin Pope

Feb 20, 2026 @ 11:53 AM J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics... Source: Vandana Singh

Feb 18, 2026 @ 10:59 PM ACTG Announces Publication of LATITUDE Findings in... Source: Actg

Feb 18, 2026 @ 3:10 PM FDA Grants Breakthrough Status To Johnson & Johnso... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$11.13	$2.12	$11.13
Diluted EPS	$11.03	$2.09	$11.03
Revenue	$94.19B	$24.56B	$94.19B
Gross Profit	$63.94B	$16.6B	$63.94B
Net Income / Loss	$26.8B	$5.12B	$26.8B
Operating Income / Loss	$32.58B	$4.97B	$32.58B
Cost of Revenue	$30.26B	$7.97B	$30.26B
Net Cash Flow	$-4396M	$1.48B	$-4396M
PE Ratio	22.39

Splits
Jun 13, 2001	2:1